Health Care & Life Sciences » Pharmaceuticals | ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
30,082.00
55,970.00
76,322.00
128,622.00
176,842.00
201,576
Cost of Goods Sold (COGS) incl. D&A
11,084.00
15,351.00
19,592.00
71,123.00
106,960.00
106,766
Gross Income
18,998.00
40,619.00
56,730.00
57,499.00
69,882.00
94,810
SG&A Expense
12,600.00
20,613.00
24,030.00
30,735.00
40,650.00
58,116
EBIT
6,398.00
20,006.00
32,700.00
26,764.00
29,232.00
36,694
Unusual Expense
6,200.00
-
-
6,685.00
903.00
1,535
Non Operating Income/Expense
95.00
160.00
41.00
74.00
55.00
550
Interest Expense
167.00
787.00
11,008.00
11,327.00
12,035.00
14,558
Pretax Income
126.00
19,379.00
21,733.00
8,678.00
16,349.00
20,051
Income Tax
20.00
9,368.00
6,358.00
4,744.00
17,425.00
4,557
Consolidated Net Income
106.00
28,588.00
15,290.00
3,913.00
1,076.00
15,340
Net Income
106.00
28,588.00
15,290.00
3,913.00
1,076.00
15,340
Net Income After Extraordinaries
89.00
28,588.00
15,290.00
3,913.00
1,076.00
15,340
Net Income Available to Common
4,674.00
28,588.00
15,290.00
3,913.00
1,076.00
15,340
EPS (Basic)
0.92
2.59
1.32
0.34
0.09
1.30
Basic Shares Outstanding
5,071.00
10,941.00
11,370.00
11,445.00
11,547.00
11,677
EPS (Diluted)
0.92
2.59
1.32
0.34
0.09
1.30
Diluted Shares Outstanding
5,071.00
11,053.00
11,557.00
11,573.00
11,547.00
11,772
EBITDA
7,508.00
23,884.00
39,600.00
49,107.00
57,160.00
70,436
Other After Tax Income (Expense)
-
159.00
85.00
21.00
-
154
Preferred Dividends
4,975.00
-
-
-
-
-

About ANI Pharmaceuticals

View Profile
Address
210 Main Street West
Baudette Minnesota 56623
United States
Employees -
Website http://www.anipharmaceuticals.com
Updated 07/08/2019
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.